Can histologic remission be a better prognostic factor and therapeutic target beyond endoscopic mucosal healing in patients with ulcerative colitis?
Hyo Jun Ahn, Sang-Bum Kang
Intest Res. 2018;16(1):1-3.   Published online 2018 Jan 18     DOI:
Citations to this article as recorded by Crossref logo
Histologic Activity and Steroid Use History Are Risk Factors of Clinical Relapse in Ulcerative Colitis With Mayo Endoscopic Subscore of 0 or 1
Gyeol Seong, Joo Hye Song, Ji Eun Kim, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Seok-Hyung Kim, Sang Yun Ha, Young-Ho Kim
Inflammatory Bowel Diseases.2022;[Epub]     CrossRef
Altered Structural Expression and Enzymatic Activity Parameters in Quiescent Ulcerative Colitis: Are These Potential Normalization Criteria?
Sebastian Kjærgaard, Morten M. B. Damm, Joan Chang, Lene B. Riis, Hanne B. Rasmussen, Rasmus Hytting-Andreasen, Susanne M. Krug, Jörg-Dieter Schulzke, Niels Bindslev, Mark Berner Hansen
International Journal of Molecular Sciences.2020; 21(5): 1887.     CrossRef